Skip to main content

Michael Paterson

Core Scientist (Full Status)
Program Lead

ICES Affiliation
  • ICES Central
  • Chronic Disease & Pharmacotherapy Research Program

416-480-4055 Ext. 3869


Contact Michael Paterson


  • MSc, Physiology, University of Toronto
  • BSc, Human Biology, University of Guelph

Research Focus

  • Drug interactions
  • Health services research
  • Health policy/reform

Other Affiliations

  • Assistant Professor, Department of Family Medicine, McMaster University
  • Assistant Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
  • Ontario Site Co-Lead, Canadian Network for Observational Drug Effect Studies (CNODES)

Recent ICES Grants

  • Filling knowledge gaps for the success of Ontario Renal Plan 3

    Principal investigator: Beaucage MB, Chanchlani R, Clark EG, Clemens KK, Coghlan C, Dixon SN, Field B, ; Harel Z, Jain AK, Molnar A, Silver S, Sood MM, Weir MA, Zappitelli M
    Co-investigators: Al-Jaishi A, Bhasin AA, Blake PG, Garg A, Harvey-Rioux L, Kitchlu A,  Knoll G, Kurdyak PA, Muanda F, Nash DM, Naylor K, Nesrallah G, Oliver MJ, Ordon M, Paterson M, Perl J, Roshanov P, Wald R, Walsh MW, Welk BK, Young A
    Canadian Institutes of Health Research, Project Grant
    2019-2020; $100,000
  • Studies on the safety of prescription opioids

    Principal investigator: Juurlink DN
    Co-investigator: Gomes T, Mamdani M, Paterson M, Zipursky JS

    Canadian Institutes of Health Research, Project Grant
    2019-2021; $120,000
  • Raising awareness of the burden of giant cell arteritis occurrence health care use costs

    Principal investigator: Barra L, Widdifield J
    Co-investigators: Jaakkimainen L, Paterson M

    CIORA - Canadian Initiative for Outcomes in Rheumatology Care, Operating Grant
    2018-2020; $115,000

Recent Awards & Recognition

  • CIHR-CMAJ Top Canadian Achievements in Health Research Awards

    2013: Awarded to Drs. Larry W. Chambers, Lisa Dolovich, Lehana Thabane, Janusz Kaczorowski, Karen Tu; and Michael Paterson and for their work in developing the Cardiovascular Health Awareness Program (CHAP). Designed to increase cardiovascular risk awareness at the community level, CHAP has demonstrated that primary prevention integrated with family physicians, community pharmacists, and community partners and volunteers can significantly reduce the burden of cardiovascular morbidity.

Recent ICES Publications

News coverage